Galiximab

Embed this Topic
Galiximab is a chimeric monoclonal antibody designed for the treatment of B-cell lymphoma. As of September 2009, it is undergoing Phase III clinical trials.
Read article at Wikipedia

Facts from the Community

From the BioVenturist base

Target/Biomolecule of Interest:

Indication or disease:

Disease Phase of development
View entire collection »

Technology involved:

Developed by:

top ↑

We can tell you that Galiximab is a…

If you know more about Galiximab, you can add more facts here »

These people have edited this topic:

  • tristan Metaweb Staff
Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for Galiximab was automatically generated from Wikipedia.org licensed under the GNU Free Documentation License.
[1]
Learn more about Freebase licensing and attribution